NEWS
-
2025/09/20We are pleased to announce our investment in FerroptoCure Inc., a company developing novel therapeutics for various diseases by leveraging the mechanisms of ferroptosis.
-
2025/09/13We are pleased to announce our investment in CORE Biomedicine, Inc., a company engaged in the research and development of pharmaceuticals, with a focus on oncology.
-
2025/07/17We are pleased to announce our investment in AMS Planning, Inc., a Hokkaido University start-up engaged in business development in the field of nuclear medicine.
-
2025/07/11We are pleased to announce our investment in TEKMOF Inc., a company leveraging its proprietary Metal Organic Framework (MOF) technology to accelerate innovation in drug discovery and related fields.
-
2025/06/04We completed the final close of our first fund ( VI No.1 Investment Limited Partnership), with a total commitment of approximately JPY 2.0 billion.
-
2025/05/29We are pleased to announce our investment in MoveEz, Inc., the world’s first company to enable autonomous driving on snowy roads.
-
2025/03/27We are pleased to announce our investment in Juro Sciences, Inc., a biotech company developing SFG-02, a new drug for the treatment of underactive bladder (UAB).
-
2024/10/21The development and global expansion of low-molecular-weight anticancer drugs, Magic Bullet, has been awarded for JST D-Global.
-
2024/08/27We joined the Japan Venture Capital Association (JVCA) as a VC member.
-
2024/03/29We published our web site.